TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
DTIL

Precision BioSciences Inc

Healthcare · Biotechnology

6.70$ +0.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Precision BioSciences Inc (DTIL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 34 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement DTIL
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
7.0 6.5 11 22 24 116 25 49 69 34
0.0 0.0 0.0 9.0 8.3 4.6 2.8
7.0 6.5 11 22 24 116 25 49 69 34
9.1 20 45 82 98 115 46 53 60 54
6.2 8.0 14 27 36 40 41 39 35 32
15 28 59 109 134 155 87 92 95 86
-8.8 -22 -48 -87 -110 -39 -62 -44 -26 -52
0.0 0.0 0.0 0.2 0.8 0.1 1.1 2.2 1.8 1.4
-8.3 -21 -46 -93 -109 -31 -73 -43 7.2 -47
0.0 -0.8 1.9 -9.6 10 0.3 11 27
-8.3 -21 -46 -93 -109 -31 -112 -61 7.2 -46
-8.2 -20 -44 -87 -99 -20 -63 -32 14 -42

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?